Published by Josh White on 3rd October 2024
(Sharecast News) - Syncona announced on Thursday that it has committed £63.5m in series B financing to Resolution Therapeutics, a portfolio company focused on macrophage therapy for inflammatory and fibrotic diseases.
URL: http://www.digitallook.com/dl/news/story/34600563/...